David R. Mauritson

799 total citations
14 papers, 557 citations indexed

About

David R. Mauritson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David R. Mauritson has authored 14 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David R. Mauritson's work include Cardiac Arrhythmias and Treatments (6 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiac pacing and defibrillation studies (5 papers). David R. Mauritson is often cited by papers focused on Cardiac Arrhythmias and Treatments (6 papers), Cardiac Imaging and Diagnostics (6 papers) and Cardiac pacing and defibrillation studies (5 papers). David R. Mauritson collaborates with scholars based in United States. David R. Mauritson's co-authors include Stacey M. Johnson, James T. Willerson, L. David Hillis, Michael D. Winniford, L.David Hillis, Brian G. Firth, W. S. G. Walker, Robert E. Rude, John R. Cary and James R. Corbett and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and The American Journal of Medicine.

In The Last Decade

David R. Mauritson

14 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David R. Mauritson United States 11 493 261 81 34 29 14 557
Masao Nagao Japan 10 428 0.9× 302 1.2× 97 1.2× 20 0.6× 33 1.1× 14 543
James L. Whittle United States 10 312 0.6× 177 0.7× 43 0.5× 20 0.6× 29 1.0× 15 390
M Chimienti Italy 12 448 0.9× 191 0.7× 66 0.8× 16 0.5× 32 1.1× 37 506
J Szlachcic United States 10 593 1.2× 380 1.5× 180 2.2× 48 1.4× 33 1.1× 14 719
Pierre Y. Tilmant France 9 578 1.2× 427 1.6× 178 2.2× 42 1.2× 31 1.1× 13 683
Robert Arbogast France 6 244 0.5× 134 0.5× 139 1.7× 49 1.4× 24 0.8× 7 350
I‐Zu Huang United States 5 425 0.9× 129 0.5× 58 0.7× 46 1.4× 69 2.4× 8 649
Anthony Alvaro United States 8 289 0.6× 205 0.8× 81 1.0× 25 0.7× 11 0.4× 12 404
Paul Broadhurst United Kingdom 11 619 1.3× 218 0.8× 141 1.7× 9 0.3× 57 2.0× 26 737
Steven J. Schang United States 7 440 0.9× 318 1.2× 97 1.2× 32 0.9× 14 0.5× 9 517

Countries citing papers authored by David R. Mauritson

Since Specialization
Citations

This map shows the geographic impact of David R. Mauritson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Mauritson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Mauritson more than expected).

Fields of papers citing papers by David R. Mauritson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Mauritson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Mauritson. The network helps show where David R. Mauritson may publish in the future.

Co-authorship network of co-authors of David R. Mauritson

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Mauritson. A scholar is included among the top collaborators of David R. Mauritson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Mauritson. David R. Mauritson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gabliani, Gregory, et al.. (1985). Ventricular ectopic activity with spontaneous variant angina: Frequency and relation to transient ST segment deviation. American Heart Journal. 110(1). 40–43. 12 indexed citations
2.
Winniford, Michael D., et al.. (1984). Concomitant calcium antagonist plus isosorbide dinitrate therapy for markedly active variant angina. American Heart Journal. 108(5). 1269–1273. 13 indexed citations
3.
Winniford, Michael D., Stacey M. Johnson, David R. Mauritson, & L. David Hillis. (1983). Ergonovine provocation to assess efficacy of long-term therapy with calcium antagonists in Prinzmetal's variant angina. The American Journal of Cardiology. 51(5). 684–688. 14 indexed citations
4.
Walker, W. S. G., Michael D. Winniford, David R. Mauritson, Stacey M. Johnson, & L.David Hillis. (1983). Atrioventricular junctional rhythm in patients receiving oral verapamil therapy.. PubMed. 249(3). 389–90. 8 indexed citations
5.
Mauritson, David R., et al.. (1983). Verapamil for unstable angina at rest: A short-term randomized, double-blind study. American Heart Journal. 106(4). 652–658. 21 indexed citations
6.
Johnson, Stacey M., David R. Mauritson, Michael D. Winniford, et al.. (1982). Continuous electrocardiographic monitoring in patients with unstable angina pectoris: Identification of high-risk subgroup with severe coronary disease, variant angina, and/or impaired early prognosis. American Heart Journal. 103(1). 4–12. 142 indexed citations
7.
Mauritson, David R., Michael D. Winniford, W. S. G. Walker, et al.. (1982). Oral Verapamil for Paroxysmal Supraventricular Tachycardia. Annals of Internal Medicine. 96(4). 409–412. 79 indexed citations
8.
Winniford, Michael D., et al.. (1982). Verapamil therapy for Prinzmetal's variant angina: Comparison with placebo and nifedipine. The American Journal of Cardiology. 50(4). 913–918. 33 indexed citations
9.
Mauritson, David R., et al.. (1982). Oral verapamil for paroxysmal supraveutricular tachycardia: A long-term, double-blind, randomized trial. The American Journal of Cardiology. 49(4). 980–980. 1 indexed citations
10.
Johnson, Stacey M., David R. Mauritson, James R. Corbett, et al.. (1981). Effects of verapamil and nifedipine on left ventricular function at rest and during exercise in patients with prinzmetal's variant angina pectoris. The American Journal of Cardiology. 47(6). 1289–1294. 13 indexed citations
11.
Johnson, Stacey M., David R. Mauritson, James T. Willerson, & L. David Hillis. (1981). A Controlled Trial of Verapamil for Prinzmetal's Variant Angina. New England Journal of Medicine. 304(15). 862–866. 123 indexed citations
12.
Mauritson, David R., et al.. (1981). Comparison of verapamil and nifedipine in the treatment of variant angina pectoris: Preliminary observations in 10 patients. The American Journal of Cardiology. 47(6). 1295–1300. 29 indexed citations
13.
Johnson, Stacey M., David R. Mauritson, James R. Corbett, et al.. (1981). Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris. The American Journal of Medicine. 71(3). 443–451. 61 indexed citations
14.
Mauritson, David R., et al.. (1981). Verapamil administration in variant angina pectoris. Efficacy shown by ecg monitoring.. PubMed. 245(18). 1849–51. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026